Korea Investment Corp Biogen Inc. Transaction History

Korea Investment Corp

$38.9 Billion
Q2 2024

A detailed history of Korea Investment Corp transactions in Biogen Inc. stock. As of the latest transaction made, Korea Investment Corp holds 95,417 shares of BIIB stock, worth $18.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

95,417

Previous 140,871 32.27%

Holding current value

$18.6 Million

Previous $30.4 Million 27.18%

% of portfolio

0.06%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $8.66 Million - $10.8 Million	-45,454 Reduced 32.27%	95,417 $22.1 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $7.4 Million - $9.35 Million	-34,924 Reduced 19.87%	140,871 $30.4 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $7.05 Million - $8.48 Million	31,659 Added 21.96%	175,795 $45.5 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $821,451 - $927,141	-3,243 Reduced 2.2%	144,136 $37 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $5.62 Million - $6.49 Million	-20,415 Reduced 12.17%	147,379 $42 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $4.42 Million - $5.04 Million	-17,244 Reduced 9.32%	167,794 $46.7 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $21.3 Million - $25.9 Million	-84,501 Reduced 31.35%	185,038 $51.2 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $8.03 Million - $11.1 Million	41,268 Added 18.08%	269,539 $72 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $10.5 Million - $12.5 Million	55,847 Added 32.39%	228,271 $46.6 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $14.4 Million - $18.1 Million	74,184 Added 75.51%	172,424 $36.3 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $4.81 Million - $6.18 Million	-21,474 Reduced 17.94%	98,240 $23.6 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $6.3 Million - $8.21 Million	-22,257 Reduced 15.68%	119,714 $33.9 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $10.5 Million - $16.8 Million	40,430 Added 39.82%	141,971 $49.2 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $30.2 Million - $35.4 Million	-124,441 Reduced 55.07%	101,541 $28.4 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $8.48 Million - $12.8 Million	35,879 Added 18.87%	225,982 $55.3 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $2.73 Million - $3.15 Million	-10,300 Reduced 5.14%	190,103 $53.9 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $2.92 Million - $3.87 Million	11,300 Added 5.98%	200,403 $53.6 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $6.24 Million - $7.91 Million	-23,200 Reduced 10.93%	189,103 $59.8 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $2.44 Million - $3.38 Million	11,100 Added 5.52%	212,303 $63 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $2.57 Million - $2.88 Million	11,800 Added 6.23%	201,203 $46.8 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $2.76 Million - $3.05 Million	12,600 Added 7.13%	189,403 $44.3 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $986,897 - $1.54 Million	-4,554 Reduced 2.51%	176,803 $41.8 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $2.56 Million - $3.25 Million	-9,200 Reduced 4.83%	181,357 $54.6 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.13 Million - $1.47 Million	3,833 Added 2.05%	190,557 $67.3 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $1.47 Million - $1.75 Million	-5,700 Reduced 2.96%	186,724 $0
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $1.41 Million - $1.99 Million	-5,409 Reduced 2.73%	192,424 $52.7 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $3.69 Million - $4.13 Million	12,000 Added 6.46%	197,833 $63 Million
Q3 2017 Oct 25, 2017	BUY	$281.15 - $329.69 $52.2 Million - $61.3 Million	185,833	185,833 $58.2 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Biogen Inc. Transaction History